NasdaqGM - Nasdaq Real Time Price USD

EDAP TMS S.A. (EDAP)

2.3000

+0.1500

+(6.98%)

At close: May 7 at 4:00:00 PM EDT

EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025

Company to host conference call and webcast on Thursday, May 15th at 8:30am EDT LYON, France, May 1, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the first quarter ended March 31, 2025, before the markets open on Thursday, May 15th, 2025. An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer

GlobeNewswire 6 days ago

EDAP
+6.98%
EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting

Final 3-year outcome of Focal Ablation versus Radical Prostatectomy (FARP) Randomized Controlled Trial (RCT) presented at 120th AUA Annual Meeting on Sunday, April 27, 2025. Study achieved its primary endpoint and demonstrated that the rate of treatment failure in the Focal Ablation (FA) group is non-inferior to that in the Radical Prostatectomy (RP) group at the final 36-month follow-up. AUSTIN, Texas, April 29, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therap

GlobeNewswire 8 days ago

EDAP
+6.98%
EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting

Focal One i expands HIFUsion® patient-specific imaging compatibility to include PSMA PET, ExactVu™ Micro-Ultrasound, along with AI-driven and intelligent algorithms including Unfold AI™ and OnQ™ ProstateFocal One i extends HIFUsion capabilities to integrate Koelis® 3D biopsy maps and DynaCAD Urology datasetsFocal One i system will enable future capabilities including treatment streaming and recording, remote collaborative procedures and expanded clinical indications AUSTIN, Texas, April 24, 2025

GlobeNewswire 13 days ago

EDAP
+6.98%
EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting

Activities to include expert-led demonstrations, semi-live Focal One procedures and hands-on simulations Final results of randomized clinical trial (FARP Study) comparing ultrasound-based focal ablation versus radical prostatectomy as a first-line treatment for prostate cancer Presentation on the first ever remote transatlantic Focal One Robotic HIFU procedure will be given by Ruben Olivares, MD, Urologic Surgeon at the Cleveland Clinic, at the AUA session of the Engineering & Urology Society No

GlobeNewswire 15 days ago

EDAP
+6.98%
EDAP TMS Full Year 2024 Earnings: Beats Expectations

EDAP TMS ( NASDAQ:EDAP ) Full Year 2024 Results Key Financial Results Revenue: €64.1m (up 6.1% from FY 2023). Net loss...

Simply Wall St. last month

EDAP
+6.98%
Edap TMS SA (EDAP) Q4 2024 Earnings Call Highlights: Strong HIFU Growth Amidst Strategic Shifts

Edap TMS SA (EDAP) reports robust HIFU revenue growth and strategic advancements, despite facing operational challenges and a shift away from non-core businesses.

GuruFocus.com last month

EDAP
+6.98%
EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

Record full-year 2024 HIFU revenue of USD 25.7 million, an increase of 15.3% over full-year 2023Record Q4 2024 HIFU revenue of USD 9.3 million, an increase of 15.0% over Q4 2023U.S. Focal One HIFU procedures grew 51% on a year-over-year basis in 2024Focal One receives CE Mark for the treatment of deep infiltrating endometriosisRecent landmark HIFI study publication demonstrates positive outcomes with Focal One® Robotic HIFU versus surgery in the management of prostate cancerFirst patients treate

GlobeNewswire last month

EDAP
+6.98%
EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Company to host conference call and webcast on Thursday, March 27th at 8:30am EDT AUSTIN, Texas, March 6, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2024, before the markets open on Thursday, March 27th, 2025. An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck

GlobeNewswire 2 months ago

EDAP
+6.98%
EDAP Appoints Glen French to Board of Directors

PDF Version LYON, France, March 3, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Glen French to its Board of Directors. “We are pleased to welcome Glen to our Board of Directors," said Dr. Lance Willsey, Interim Chairman of the Board of EDAP TMS. “Glen is a highly accomplished executive with extensive business and clinical expertise in the development of innovative new medical devices and tech

GlobeNewswire 2 months ago

EDAP
+6.98%
Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center

First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California, San Francisco Prostate Cancer CenterOnQ Prostate’s Restriction Spectrum Imaging (RSI) technology improves lesion localization and targeting for urologists performing Focal One Robotic High Intensity Focused Ultrasound (HIFU) ablation Reflects EDAP’s continued commitment to innovation and further validates Focal One as the leading focal therapy

GlobeNewswire 2 months ago

EDAP
+6.98%
EDAP TMS (NASDAQ:EDAP) investors are sitting on a loss of 68% if they invested three years ago

If you love investing in stocks you're bound to buy some losers. But the long term shareholders of EDAP TMS S.A...

Simply Wall St. 3 months ago

EDAP
+6.98%
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures

Company Reports Preliminary Worldwide Record Fourth Quarter Sales of 11 Focal One Systems Record U.S. Fourth Quarter Focal One System Sales Record Number of U.S. Focal One Procedures, with Year-Over-Year Growth of 30% PDF Version AUSTIN, Texas, January 13, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced preliminary record Focal One System sales for the fourth quarter of calendar year 2024. The Company experienced

GlobeNewswire 3 months ago

EDAP
+6.98%
EDAP Appoints Joshua H. Levine to Board of Directors

PDF Version AUSTIN, Texas, January 10, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Joshua H. Levine to its Board of Directors. “We are pleased to welcome Josh Levine to our Board of Directors," said Dr. Lance Willsey, Interim Chairman of the Board of EDAP TMS. “Josh brings a wealth of executive experience and a track record of growing shareholder value by focusing on transformative, high gro

GlobeNewswire 3 months ago

EDAP
+6.98%
EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology

AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Léon Bérard, Lyon, France, evaluating proprietary High Intensity Focused Ultrasound (HIFU) technology for the treatment of pancreatic tumors. “The initiation of the PULS Trial represents a major milestone in efforts to develop a new and innovative approach for treating this deva

GlobeNewswire 3 months ago

EDAP
+6.98%
Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer

HIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer treatmentsPositive study results are expected to drive further adoption of Focal One as a first line treatment option for the management of localized prostate cancer Study shows Focal One Robotic HIFU is non-inferior to surgery, meeting primary endpoint of non-inferiority for Salvage Treatment-free Survival (STFS) after High Intensity Focused Ultrasounds (HIFU) com

GlobeNewswire 4 months ago

EDAP
+6.98%
Senti Bio Appoints Fran Schulz to Board of Directors

Biotechnology industry executive with a proven track record of advising management teams on corporate and financial strategy for more than 30 yearsSOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it has appointed Fran Schulz, a highly experienced biotechnolog

GlobeNewswire 5 months ago

EDAP
+6.98%

SNTI
EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference

LYON, France, November 27, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer of EDAP TMS, is scheduled to participate in a fireside discussion and host 1x1 investor meetings at the upcoming Piper Sandler 36th Annual Healthcare Conference, which is taking place from December 3-5, 2024, in New York City. Presentation Details: Piper Sandler 36th Annual Healthcare Conference Format: Fireside Discussion Date: Tu

GlobeNewswire 5 months ago

EDAP
+6.98%
EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting

Early feasibility work demonstrates Focal One system’s ability to generate histotripsy lesions ex vivo LYON, France, November 22, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced a scientific presentation which demonstrated the technical feasibility of performing non-thermal histotripsy energy delivery and generating histotripsy lesions in biological tissues ex vivo using the Company’s Focal One® Robotic HIFU technology. The results from the

GlobeNewswire 5 months ago

EDAP
+6.98%
EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis

Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgery LYON, France, November 19, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced a moderated scientific presentation of clinical data comparing Focal One HIFU versus surgery for the treatment of deep infiltrating endometriosis at the 2024 AAGL Global Congress, which took place from November 16-19, 2024, in

GlobeNewswire 5 months ago

EDAP
+6.98%
EDAP TMS Third Quarter 2024 Earnings: Misses Expectations

EDAP TMS ( NASDAQ:EDAP ) Third Quarter 2024 Results Key Financial Results Revenue: €13.1m (up 12% from 3Q 2023). Net...

Simply Wall St. 5 months ago

EDAP
+6.98%

Performance Overview

Return	EDAP	MSCI WORLD (^990100-USD-STRD)
YTD	+5.50%	-0.42%
1-Year	-67.61%	+8.74%
3-Year	-63.14%	--

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

EDAP TMS S.A. (EDAP)

EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025

EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting

EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting

EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting

EDAP TMS Full Year 2024 Earnings: Beats Expectations

Edap TMS SA (EDAP) Q4 2024 Earnings Call Highlights: Strong HIFU Growth Amidst Strategic Shifts

EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

EDAP Appoints Glen French to Board of Directors

Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center

EDAP TMS (NASDAQ:EDAP) investors are sitting on a loss of 68% if they invested three years ago

EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures

EDAP Appoints Joshua H. Levine to Board of Directors

EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology

Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer

Senti Bio Appoints Fran Schulz to Board of Directors

EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference

EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting

EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis

EDAP TMS Third Quarter 2024 Earnings: Misses Expectations

Performance Overview